325 related articles for article (PubMed ID: 12969264)
21. The polyphenol piceid destabilizes preformed amyloid fibrils and oligomers in vitro: hypothesis on possible molecular mechanisms.
Rivière C; Delaunay JC; Immel F; Cullin C; Monti JP
Neurochem Res; 2009 Jun; 34(6):1120-8. PubMed ID: 19030989
[TBL] [Abstract][Full Text] [Related]
22. Anti-amyloidogenic effects of soybean isoflavones in vitro: Fluorescence spectroscopy demonstrating direct binding to Aβ monomers, oligomers and fibrils.
Hirohata M; Ono K; Takasaki J; Takahashi R; Ikeda T; Morinaga A; Yamada M
Biochim Biophys Acta; 2012 Aug; 1822(8):1316-24. PubMed ID: 22587837
[TBL] [Abstract][Full Text] [Related]
23. Inhibitors of amyloid beta-protein aggregation mediated by GM1-containing raft-like membranes.
Matsuzaki K; Noguch T; Wakabayashi M; Ikeda K; Okada T; Ohashi Y; Hoshino M; Naiki H
Biochim Biophys Acta; 2007 Jan; 1768(1):122-30. PubMed ID: 17069749
[TBL] [Abstract][Full Text] [Related]
24. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.
Zhang W; Du Y; Bai M; Xi Y; Li Z; Miao J
J Pept Sci; 2013 Mar; 19(3):159-65. PubMed ID: 23349038
[TBL] [Abstract][Full Text] [Related]
25. Blood-borne factors inhibit Alzheimer's beta-amyloid fibril formation in vitro.
Ono K; Noguchi-Shinohara M; Samuraki M; Matsumoto Y; Yanase D; Iwasa K; Naiki H; Yamada M
Exp Neurol; 2006 Nov; 202(1):125-32. PubMed ID: 16806179
[TBL] [Abstract][Full Text] [Related]
26. Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease.
Bastianetto S; Krantic S; Quirion R
Mini Rev Med Chem; 2008 May; 8(5):429-35. PubMed ID: 18473932
[TBL] [Abstract][Full Text] [Related]
27. A carboxylated Zn-phthalocyanine inhibits fibril formation of Alzheimer's amyloid β peptide.
Tabassum S; Sheikh AM; Yano S; Ikeue T; Handa M; Nagai A
FEBS J; 2015 Feb; 282(3):463-76. PubMed ID: 25404240
[TBL] [Abstract][Full Text] [Related]
28. Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
Hirohata M; Ono K; Naiki H; Yamada M
Neuropharmacology; 2005 Dec; 49(7):1088-99. PubMed ID: 16125740
[TBL] [Abstract][Full Text] [Related]
29. Resolution of localized small molecule-Aβ interactions by deep-ultraviolet resonance Raman spectroscopy.
Wang M; Jiji RD
Biophys Chem; 2011 Oct; 158(2-3):96-103. PubMed ID: 21652140
[TBL] [Abstract][Full Text] [Related]
30. Toxicity of non-abeta component of Alzheimer's disease amyloid, and N-terminal fragments thereof, correlates to formation of beta-sheet structure and fibrils.
Bodles AM; Guthrie DJ; Harriott P; Campbell P; Irvine GB
Eur J Biochem; 2000 Apr; 267(8):2186-94. PubMed ID: 10759841
[TBL] [Abstract][Full Text] [Related]
31. In vitro antiaggregation and deaggregation potential of Rhizophora mucronata and its bioactive compound (+)- catechin against Alzheimer's beta amyloid peptide (25-35).
Suganthy N; Sheeja Malar D; Pandima Devi K
Neurol Res; 2016 Dec; 38(12):1041-1051. PubMed ID: 27766923
[TBL] [Abstract][Full Text] [Related]
32. Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain.
Castillo GM; Lukito W; Peskind E; Raskind M; Kirschner DA; Yee AG; Snow AD
J Neurosci Res; 2000 Nov; 62(3):451-62. PubMed ID: 11054814
[TBL] [Abstract][Full Text] [Related]
33. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein.
Akaishi T; Morimoto T; Shibao M; Watanabe S; Sakai-Kato K; Utsunomiya-Tate N; Abe K
Neurosci Lett; 2008 Oct; 444(3):280-5. PubMed ID: 18761054
[TBL] [Abstract][Full Text] [Related]
34. Anthocyanin suppresses the toxicity of Aβ deposits through diversion of molecular forms in in vitro and in vivo models of Alzheimer's disease.
Yamakawa MY; Uchino K; Watanabe Y; Adachi T; Nakanishi M; Ichino H; Hongo K; Mizobata T; Kobayashi S; Nakashima K; Kawata Y
Nutr Neurosci; 2016; 19(1):32-42. PubMed ID: 26304685
[TBL] [Abstract][Full Text] [Related]
35. Critical role of interfaces and agitation on the nucleation of Abeta amyloid fibrils at low concentrations of Abeta monomers.
Morinaga A; Hasegawa K; Nomura R; Ookoshi T; Ozawa D; Goto Y; Yamada M; Naiki H
Biochim Biophys Acta; 2010 Apr; 1804(4):986-95. PubMed ID: 20100601
[TBL] [Abstract][Full Text] [Related]
36. Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs.
Espargaró A; Ginex T; Vadell MD; Busquets MA; Estelrich J; Muñoz-Torrero D; Luque FJ; Sabate R
J Nat Prod; 2017 Feb; 80(2):278-289. PubMed ID: 28128562
[TBL] [Abstract][Full Text] [Related]
37. Abeta20-29 peptide blocking apoE/Abeta interaction reduces full-length Abeta42/40 fibril formation and cytotoxicity in vitro.
Hao J; Zhang W; Zhang P; Liu R; Liu L; Lei G; Su C; Miao J; Li Z
Neuropeptides; 2010 Aug; 44(4):305-13. PubMed ID: 20363024
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity.
Bastianetto S; Yao ZX; Papadopoulos V; Quirion R
Eur J Neurosci; 2006 Jan; 23(1):55-64. PubMed ID: 16420415
[TBL] [Abstract][Full Text] [Related]
39. Dimeric bis (heptyl)-Cognitin Blocks Alzheimer's β-Amyloid Neurotoxicity Via the Inhibition of Aβ Fibrils Formation and Disaggregation of Preformed Fibrils.
Hu SQ; Wang R; Cui W; Mak SH; Li G; Hu YJ; Lee MY; Pang YP; Han YF
CNS Neurosci Ther; 2015 Dec; 21(12):953-61. PubMed ID: 26507365
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro.
Wei CW; Peng Y; Zhang L; Huang Q; Cheng M; Liu YN; Li J
Bioorg Med Chem Lett; 2011 Oct; 21(19):5818-21. PubMed ID: 21855336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
